250 Mg Abiraterone Acetate Tablets
250 Mg Abiraterone Acetate Tablets

250 Mg Abiraterone Acetate Tablets

Price 4499 INR/ Bottle

MOQ : 1 Bottle

250 Mg Abiraterone Acetate Tablets Specification

  • Dosage Form
  • Tablet
  • Indication
  • Treatment of metastatic castration-resistant prostate cancer
  • Salt Composition
  • Abiraterone Acetate 250 mg
  • Feature
  • Prescription medicine for oral administration
  • Ingredients
  • Abiraterone Acetate and excipients
  • Application
  • Oncology, Cancer Therapy
  • Physical Color/Texture
  • White to off-white, oval, film-coated tablet
  • Fermentation Smell
  • Odorless
  • Storage Instructions
  • Store at 20C to 25C (68F to 77F), excursions permitted between 15C and 30C
  • Shelf Life
  • 24 months
  • Caution
  • Monitor liver function and potassium levels during therapy
  • Regulatory Status
  • WHO-GMP/Approved by National Regulatory Authority
  • Patient Population
  • Adult males with prostate cancer
  • Marketed By
  • Leading pharmaceutical distributor
  • Common Side Effects
  • Hypertension, hypokalemia, fluid retention, liver function abnormalities
  • Warning
  • To be used under medical supervision only. Not for use in women or children.
  • Strength
  • 250 mg per tablet
  • Primary Function
  • CYP17 enzyme inhibitor for androgen biosynthesis suppression
  • Tablet Size
  • Standard oval tablet approximately 16 mm length
  • Prescription/Non-prescription
  • Prescription Only
  • Contraindications
  • Hypersensitivity to Abiraterone or excipients; severe hepatic impairment
  • Packaging Type
  • Box containing blister strips
  • Administration Route
  • Oral
 
 

About 250 Mg Abiraterone Acetate Tablets



Last Chance to find a brilliant solution for metastatic castration-resistant prostate cancer with 250 mg Abiraterone Acetate Tablets. Scarce in availability, this pivotal therapy is valorous in suppressing androgen biosynthesis by inhibiting the CYP17 enzyme. Each standard oval tablet (16 mm) is packaged in a box with blister strips and is designed exclusively for oral administration under prescription. Marketed by a leading distributor in India, these tablets meet WHO-GMP standards and regulatory approval. For adult males only, not for women or children. Medical supervision is mandatory.

Exceptional Usage & Applications in Oncology

250 Mg Abiraterone Acetate Tablets are used in cancer therapy, specifically for the treatment of metastatic castration-resistant prostate cancer in adult males. With a pivotal role as a CYP17 enzyme inhibitor, these tablets are renowned in commercial oncology applications. Their primary competitive advantage lies in exceptional regulatory approval, superior efficacy, and standardized packaging, ensuring reliable supply for hospitals, clinics, and pharmacies.


Impressive Certifications & Delivery Proposal

Certified by WHO-GMP and approved by the National Regulatory Authority, 250 Mg Abiraterone Acetate Tablets come in secure blister strip packaging. Proposal amounts can be tailored to meet various supply requirements, with an estimated delivery time that ensures timely distribution across locations. Shelf life is 24 months, preserving potency. Consistent supply abilities are maintained for bulk and export orders.


FAQ's of 250 Mg Abiraterone Acetate Tablets:


Q: How should 250 Mg Abiraterone Acetate Tablets be administered for optimal benefit?

A: These tablets are intended for oral administration in adult males under strict medical supervision. It is vital to follow the prescribed dosage and monitor liver function and potassium levels during therapy to maximize safety and efficacy.

Q: What is the primary function of Abiraterone Acetate 250 mg in cancer therapy?

A: Abiraterone Acetate acts as a CYP17 enzyme inhibitor, suppressing androgen biosynthesis, which is a pivotal step in treating metastatic castration-resistant prostate cancer.

Q: When is Abiraterone Acetate contraindicated for use?

A: Abiraterone Acetate should not be used in individuals with hypersensitivity to its ingredients or excipients and those with severe hepatic impairment.

Q: Where is 250 Mg Abiraterone Acetate Tablets manufactured and distributed?

A: These tablets are marketed and distributed by a leading pharmaceutical supplier in India, compliant with WHO-GMP certification and National Regulatory Authority approval.

Q: What precautions are necessary during therapy with Abiraterone Acetate?

A: Patients should have liver function and potassium levels assessed regularly. Additionally, this medication is only for adult males, not intended for use by women or children.

Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

More Products in Cancer Drugs Category

50 Mg Cisplatin Injection IP

50 Mg Cisplatin Injection IP

Price 199 INR / Vial

Minimum Order Quantity : 1 Vial

Application : Other, Antineoplastic (Chemotherapy agent)

Dosage Form : Injection

Physical Color/Texture : Other , Clear, colorless to pale yellow solution

Shelf Life : 24 months

500 Mg Capecitabine Tablets IP

500 Mg Capecitabine Tablets IP

Price 299 INR / Strip

Minimum Order Quantity : 1 Strip

Application : Other, Oral use in chemotherapy regimens

Dosage Form : Tablet

Physical Color/Texture : Other , Filmcoated, light peachcolored tablets

Shelf Life : 24 Months

250 Mg Temozolomide Capsules IP

250 Mg Temozolomide Capsules IP

Price 999 INR / Bottle

Minimum Order Quantity : 1 Bottle

Application : Other, Anticancer drug, Oral administration for treatment of malignant gliomas

Dosage Form : Capsule

Physical Color/Texture : Other , White to offwhite powder filled in hard gelatin capsule

Shelf Life : 24 months from the date of manufacture

40 Enzalutamide Capsules

40 Enzalutamide Capsules

Price 12000 INR / Box

Minimum Order Quantity : 1 Box

Application : Other, Oral use, anticancer therapy

Dosage Form : Capsule

Physical Color/Texture : Other , White to offwhite powderfilled hard gelatin capsules

Shelf Life : 2436 months



Back to top